chr2-61873242-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_006430.4(CCT4):​c.969G>A​(p.Met323Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000432 in 1,390,036 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000043 ( 0 hom. )

Consequence

CCT4
NM_006430.4 missense

Scores

7
7
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.75

Publications

0 publications found
Variant links:
Genes affected
CCT4 (HGNC:1617): (chaperonin containing TCP1 subunit 4) The chaperonin containing TCP1 (MIM 186980) complex (CCT), also called the TCP1 ring complex, consists of 2 back-to-back rings, each containing 8 unique but homologous subunits, such as CCT4. CCT assists the folding of newly translated polypeptide substrates through multiple rounds of ATP-driven release and rebinding of partially folded intermediate forms. Substrates of CCT include the cytoskeletal proteins actin (see MIM 102560) and tubulin (see MIM 191130), as well as alpha-transducin (MIM 139330) (Won et al., 1998 [PubMed 9819444]).[supplied by OMIM, Mar 2008]
CCT4 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCT4NM_006430.4 linkc.969G>A p.Met323Ile missense_variant Exon 9 of 14 ENST00000394440.8 NP_006421.2 P50991-1
CCT4NM_001256721.1 linkc.879G>A p.Met293Ile missense_variant Exon 8 of 13 NP_001243650.1 P50991-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCT4ENST00000394440.8 linkc.969G>A p.Met323Ile missense_variant Exon 9 of 14 1 NM_006430.4 ENSP00000377958.3 P50991-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000432
AC:
6
AN:
1390036
Hom.:
0
Cov.:
25
AF XY:
0.00000287
AC XY:
2
AN XY:
695704
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
31764
American (AMR)
AF:
0.00
AC:
0
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25616
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39390
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84558
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5582
European-Non Finnish (NFE)
AF:
0.00000573
AC:
6
AN:
1047206
Other (OTH)
AF:
0.00
AC:
0
AN:
57946
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000056), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.333
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 08, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.969G>A (p.M323I) alteration is located in exon 9 (coding exon 9) of the CCT4 gene. This alteration results from a G to A substitution at nucleotide position 969, causing the methionine (M) at amino acid position 323 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.16
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T;.
Eigen
Uncertain
0.63
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D
M_CAP
Benign
0.019
T
MetaRNN
Uncertain
0.69
D;D
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Benign
2.0
M;.
PhyloP100
7.8
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-2.0
N;N
REVEL
Uncertain
0.43
Sift
Benign
0.056
T;T
Sift4G
Uncertain
0.047
D;D
Polyphen
0.52
P;.
Vest4
0.86
MutPred
0.57
Gain of sheet (P = 0.0101);.;
MVP
0.30
MPC
0.84
ClinPred
0.85
D
GERP RS
5.8
Varity_R
0.75
gMVP
0.81
Mutation Taster
=7/93
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1279688851; hg19: chr2-62100377; API